European launch of Medtronic’s Corsano™ multi-parameter wearable - a breakthrough in continuous vital signs monitoring

Now launching across Europe, the Corsano™ multi-parameter wearable is a first-of-its- kind wearable device developed for use in surgical patients under medical supervision. Delivered by hospital teams and integrated into routine care pathways, it provides continuous, real-time monitoring of eight vital signs, from pre-op to post-discharge and supporting early intervention and informed decision-making across surgical care settings.    Distributed by Medtronic, the wearable is engineered to integrate seamlessly into hospital workflows, supporting clinicians with continuous insights to detect deterioration earlier, reduce complications, and inform critical decision-making across care settings.    With traditional manual checks typically performed every 4–6 hours, patients are often unmonitored up to 96% of the time¹.   The Corsano™ wearable closes this gap with round-the-clock monitoring, helping reduce the risk of adverse events and unplanned ICU admissions - a key challenge in under-resourced health systems†.    Unplanned ICU admissions are often triggered by undetected deterioration. Studies show that continuous monitoring supports earlier clinical intervention and improved patient outcomes.² ³    Hospitals using continuous wearable monitoring have reported an average reduction in length of stay by 3.32 days, improving bed turnover and reducing pressure on hospital capacity. ⁴    Almost 30% of post-operative deaths occur after discharge. ⁵ The Corsano™ device enables extended monitoring into this high-risk period, helping ensure safer, more informed discharge decisions.    The Corsano™ wearable is lightweight, non-invasive and water-resistant, with a 7-day battery life and a patient-facing app that allows individuals to track their recovery in real time.    References   † Based on studies done on devices using same or some of the same monitoring parameters as the Corsano™ multi-parameter wearable. 

1. Curry JP, Jungquist CR. A critical assessment of monitoring practices, patient deterioration, and alarm fatigue on inpatient wards: a review. Patient Saf Surg. 2014 Jun 27;8:29. doi:10.1186/1754-9493-8-29. PMID: 25093041; PMCID: PMC4109792. 
2. Eddahchouri Y, Peelen RV, Koeneman M, et al. Effect of continuous wireless vital sign monitoring on unplanned ICU admissions and rapid response team calls: a before-and-after study. Br J Anaesth. 2022 May 1;128(5):857-63. 
3. Rowland BA, Motamedi V, Michard F, et al. Impact of continuous and wireless monitoring of vital signs on clinical outcomes: a propensity-matched observational study of surgical ward patients. Br J Anaesth. 2024 Mar 1;132(3):519-27. 
4. Downey C, Randell R, Brown J, Jayne DG. Continuous versus intermittent vital signs monitoring using a wearable, wireless patch in patients admitted to surgical wards: pilot cluster randomized controlled trial. J Med Internet Res. 2018;20(12):e10802. 
5. Spence J, et al. Association between complications and death within 30 days after noncardiac surgery. CMAJ. 2019 Jul 29;191(30):E830-E837. doi:10.1503/cmaj.190221. PMID: 31358597; PMCID: PMC6663503.